Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Quidelortho Corp - SIC # 8071 - MEDICAL LABORATORIES
Ticker
Exchange
SIC #
Website
Latest Ticker
QDEL
Nasdaq
8071
https://www.quidelortho.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Quidelortho Corp
QuidelOrtho to lay off employees after firing CEO
- Mar 14th, 2024 11:23 am
QuidelOrtho Receives Health Canada Approval for Quidel® Triage® PLGF Test for Laboratory Use in Canada
- Mar 6th, 2024 9:35 pm
QuidelOrtho to Participate in 45th Annual Raymond James Institutional Investor Conference
- Feb 26th, 2024 9:30 pm
QuidelOrtho Announces Changes in Executive Leadership
- Feb 21st, 2024 12:30 pm
QuidelOrtho fires CEO Doug Bryant
- Feb 21st, 2024 10:27 am
QuidelOrtho Full Year 2023 Earnings: Misses Expectations
- Feb 15th, 2024 11:16 am
QuidelOrtho Corp (QDEL) Reports Mixed Results Amidst Respiratory Revenue Decline
- Feb 13th, 2024 9:40 pm
QuidelOrtho Reports Fourth Quarter and Full-Year 2023 Financial Results
- Feb 13th, 2024 9:05 pm
QuidelOrtho to Report Fourth Quarter and Full-year 2023 Financial Results
- Jan 23rd, 2024 12:00 pm
Investors in QuidelOrtho (NASDAQ:QDEL) have unfortunately lost 59% over the last three years
- Dec 26th, 2023 1:01 pm
QuidelOrtho to Present at 42nd Annual J.P. Morgan Healthcare Conference
- Dec 22nd, 2023 12:00 pm
QuidelOrtho Receives 510(K) Clearance for Savanna® Multiplex Molecular Platform and Savanna® HSV 1+2/VZV PCR Assay
- Dec 20th, 2023 9:05 pm
Why is QuidelOrtho (QDEL) a Good Stock to Invest in?
- Dec 13th, 2023 10:10 am
QuidelOrtho to Participate in the Evercore ISI Conference
- Nov 16th, 2023 10:05 pm
QuidelOrtho Corp (QDEL) Reports Q3 2023 Financial Results: Revenue at $744 Million
- Nov 1st, 2023 9:56 pm
QuidelOrtho Reports Third Quarter 2023 Financial Results
- Nov 1st, 2023 8:05 pm
Powerful Lyme Disease Awareness PSA Featuring Christopher Meloni Illuminates Times Square
- Oct 17th, 2023 7:43 pm
QuidelOrtho Reports Preliminary Revenue Results for the Third Quarter 2023
- Oct 12th, 2023 11:00 am
QuidelOrtho Receives CLIA Waiver for Sofia® 2 SARS Antigen+ FIA
- Sep 21st, 2023 8:05 pm
Should You Add QuidelOrtho (QDEL) to Your Portfolio?
- Sep 21st, 2023 11:02 am
Scroll